Get started
Author

Victor Manuel Oyervides Juarez

Observed names: V. Oyervides, V. Oyervides Juarez, V. Oyervides Juárez, V.M. Oyervides Juárez, V.M. Oyervides-Juarez, V.M. Oyervides-Juárez, VM Oyervides-Juarez, Victor M. Oyervides Juárez, Victor M. Oyervides-Juárez, Victor Oyervides, Victor Oyervides Juarez, Victor Oyervides-Juarez, Victor Oyervides-Juárez, Víctor M. Oyervides-Juárez, Víctor Manuel Oyervides-Juárez, Víctor Oyervides, Víctor Oyervides‑Juárez, ez Víctor Manuel Oyervides Juárez
Observed institutions: National Health Service, Brigham and Women's Hospital, Harvard University, Mexican Social Security Institute, Queen Mary University of London, Universidad Autónoma de Nuevo León, The Royal Free Hospital, Cancer Research UK, Dana-Farber Cancer Institute, Hospital Universitario Dr José Eleuterio Gonzalez, Medicina, Dana-Farber Brigham Cancer Center, Barts Cancer Institute
ORCID: 0000-0002-6037-5248
Observed ORCID: 0000-0002-6037-5248
OpenAlex ID: A5016413037
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
2021 · Toni K. Choueiri, Thomas Powles, et al. · New England Journal of Medicine · 1,902
PDF
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
2023 · Shukui Qin, Minshan Chen, et al. · The Lancet · 602
PDF
696O_PR Nivolumab + cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma: First results from the randomized phase III CheckMate 9ER trial
2020 · T.K. Choueiri, T. Powles, et al. · Annals of Oncology · 117
PDF
Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase III JAVELIN Renal 101 trial
2024 · T.K. Choueiri, K. Penkov, et al. · Annals of Oncology · 80
PDF
A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM population
2022 · David Heredia, Luis Mas, et al. · Lung Cancer · 18
Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 Study
2026 · Lisa Licitra, Makoto Tahara, et al. · Journal of Clinical Oncology · 11
Protocol for Desensitization to Atezolizumab and Bevacizumab After Severe Anaphylaxis in the Treatment of Lung Adenocarcinoma
2020 · SN Gonzalez-Diaz, RV Villarreal-Gonzalez, et al. · Journal of Investigational Allergology and Clinical Immunology · 11
PDF
Safety and oncological effectiveness after desensitization in patients with previous hypersensitivity reactions to chemotherapy
2024 · Rosalaura V. Villarreal-González, Oscar Vidal-Gutiérrez, et al. · Journal of Oncology Pharmacy Practice · 2
Collision tumor of the kidney composed of clear cell carcinoma and collecting duct carcinoma treated with cabozantinib and nivolumab
2020 · Carlos Eduardo Salazar-Mejía, Víctor Manuel Oyervides-Juárez, et al. · Current Problems in Cancer Case Reports · 2
PDF
IGG4-Related disease: results from a multicenter panlar (Panamerican League of Associations for Rheumatology) Study group registry
2020 · Eduardo Martín Nares, Diego Federico Baenas, et al. · JCR Journal of Clinical Rheumatology · 2
Quantitative analysis of lymphocyte exhaustion markers in patients with localized clear cell renal cell carcinoma
2025 · Raquel González‑Garza, Adrián Gutiérrez‑González, et al. · Oncology Letters · 1
PDF
M030 Desensitization and Stepped Reintroduction in Anaphylaxis to Pegylated Liposomal Doxorubicin in Kaposi's Sarcoma
2021 · M. Salinas Diaz, R. Villarreal Gonzalez, et al. · Annals of Allergy Asthma & Immunology · 1
Cardiac power as prognostic marker in cardiogenic shock in acute myocardial infarction
2009 · na Carlos Gerardo Esquivel Molina, os Lucio Chávez Landeros, et al. · Medicina Interna de México · 1
Management of pulmonary nodules across Latin America: A real-world observational study.
2026 · Danilo Lopes, Luis Fernando Tejado Gallegos, et al. · Journal of Clinical Oncology
Immuno-inflammatory, genetic, and social factors of cancer cachexia in the Hispanic/Latino population: A scoping review protocol
2026 · Jesús Ángel Gracia Báez, Bianka Guadalupe Chávez Onofre, et al. · OSF Preprints (OSF Preprints)
Intracardiac Ewing-Like Sarcoma: A Diagnostic and Therapeutic Challenge
2026 · Victor Oyervides-Ortiz, Leonel Gomez-Llanos, et al. · Cureus
PDF
Resistance mutations in lung cancer: A perspective from the Mexican population.
2025 · Victor Oyervides, Marianela Madrazo-Morales, et al. · Journal of Clinical Oncology
Study on the Epidemiological Characteristics, Treatment Patterns, and Factors Influencing the Timeliness of Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC) in Stages III and IV: Experience of a Mexican Hospital
2025 · Victor Manuel Oyervides Juarez, Daneli Ruiz Sanchez, et al. · Journal of Personalized Medicine
PDF
Clinical characteristics and treatment patterns in early-stage resected non-small cell lung cancer patients: a descriptive retrospective study
2024 · Jerónimo Rodriguez-Cid, Whaley J. J. Juaréz-Vignon, et al. · Clinical innovations in health research-HJM
The innovation of mediastinal staging in lung cancer with artificial intelligence
2024 · Víctor M. Oyervides-Juárez, Alder E. Perales-Mendoza, et al. · Medicina Universitaria
PDF
Prevalence of NTRK gene fusions in solid tumors in northeastern Mexico.
2024 · Christopher Cerda-Contreras, Victor Oyervides, et al. · Journal of Clinical Oncology
PDF
EPH190 Clinical Characteristics and Treatment Patterns of Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients in Mexico
2023 · M.A. Flores- Caballero, G. Lugo-Martinez, et al. · Value in Health
PDF
EPH81 Clinical Characteristics and Treatment Patterns of Patients With Early-Stage Non-Small Cell Lung Cancer (NSCLC)
2023 · M.A. Flores- Caballero, G. Lugo-Martinez, et al. · Value in Health
PDF
EPH136 Treatment Patterns and Epidemiological Characteristics in Adult Patients With III-IVB HNSCC From a Reference Center in Mexico
2023 · J. Manzo-Merino, G. Lugo-Martinez, et al. · Value in Health
PDF
Webapp for Data Recollection and Presentation in a Head and Neck Tumor Board
2023 · J.F. Munoz Lozano, I.V. Hernandez Davila, et al. · International Journal of Radiation Oncology*Biology*Physics
Works count: 31
Citation count: 2,750
H-index: 7
I10-index: 7
Year
Topic
Type